Navigation Links
UCI stem cell researchers to receive $9.35 million in state funding
Date:10/22/2010

Irvine, Calif., Oct. 21, 2010 UC Irvine scientists will receive grants totaling $9.35 million to help create stem cell treatments for retinitis pigmentosa, Huntington's disease and traumatic brain injury.

The grants from the California Institute for Regenerative Medicine were awarded Thursday, Oct. 21, to Dr. Henry Klassen, Leslie M. Thompson, Brian Cummings and Aileen Anderson all members of the Sue and Bill Gross Stem Cell Research Center at UCI to support early-stage translational research.

CIRM's governing board gave 19 such grants worth $67 million to 12 institutions statewide. The research funded by these awards is considered critical to CIRM's mission of translating basic discoveries into clinical cures. The selected projects are expected to either result in candidate drugs or cell therapies or make significant strides toward such treatments, which can then be developed for submission to the Food & Drug Administration for clinical trial.

These grants bring total CIRM funding for UCI to $71.85 million.

"I am delighted that CIRM has made these awards to my colleagues. It speaks to the breadth of outstanding stem cell research at UC Irvine," said Peter Donovan, director of the Sue and Bill Gross Stem Cell Research Center. "The studies they will carry out on eye diseases, Huntington's and traumatic brain injury could have wider implications for the use of stem cells to treat a variety of human diseases, disorders and injuries and could have a major impact."

With a $3.85 million grant, Klassen, assistant professor of ophthalmology, will target a stem cell treatment for retinitis pigmentosa, an inherited form of blindness in which the light-detecting cells in the retina are destroyed. To counteract this, Klassen plans to standardize a method to create photoreceptor progenitor stem cells from immature retinas and then transplant these cells into the eye to repair or replace damaged light-sensing cells. The CIRM grant reviewers gave Klassen's proposal the highest scientific score 93 on a scale of 100 among all applicants for early translational grants. "The eye is an important proving ground for stem cell-based therapies and provides a stepping stone to many otherwise incurable diseases of the brain and spinal cord," he said.

With a $3.8 million grant, Thompson, professor of psychiatry & human behavior and neurobiology & behavior, will develop a technique using stem cells to support areas of the brain susceptible to Huntington's disease, an inherited, incurable and fatal neurodegenerative disorder. "These cells offer a possible long-term treatment approach that could relieve the tremendous suffering experienced by patients and their families," she said.

In 2008, Thompson received a $1.4 million CIRM grant to create human embryonic and adult-derived stem cell lines from individuals carrying the Huntington's genetic mutation in order to study the disease.

With a $1.7 million grant, Cummings and Anderson, both associate professors of physical medicine & rehabilitation and anatomy & neurobiology, will explore utilizing neural stem cells to treat traumatic brain injury, which devastates 1.4 million Americans each year. The researchers believe these cells, when introduced into the injury site, will grow into new neurons, replacing damaged and dead ones, and facilitate recovery. They plan to develop a number of stem cell lines for addressing traumatic brain injury. "If successful, these lines would be potentially useful for treating a variety of other central nervous system disorders, including Alzheimer's, Parkinson's, stroke, spinal cord injury and multiple sclerosis," Cummings said.

Earlier this year, he, Anderson and UCI neurobiology researcher Hal Nguyen were awarded a CIRM basic biology grant of $1.3 million to study the properties of induced pluripotent stem cells to learn whether these cells could treat central nervous system injury and disease.

The four researchers' work will take place in Sue and Bill Gross Hall: A CIRM Institute, an $80 million, 100,000-square-foot structure that opened on campus in May, becoming the first major stem cell facility in Southern California.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California -- Irvine
Source:Eurekalert

Related medicine news :

1. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Researchers discover new way to kill pediatric brain tumors
4. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
5. Researchers create drug to keep tumor growth switched off
6. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Clemson researchers develop hands-free texting application
9. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
10. Researchers chart genomic map spanning over 2 dozen cancers
11. Researchers discover second protective role for tumor-suppressor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Today, the Whole-Food Warrior TV show, ... much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, will stream on ... week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights Whole-Food Warriors - ...
(Date:2/5/2016)... New York, New York (PRWEB) , ... February 05, 2016 , ... ... your life? The answer may be at the tips of your toes. Foot massage, ... benefits as well as pure comfort and relaxation. The American Board of Multiple ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth quarter of ... at the La Valencia Hotel in San Diego, California to discuss changes in ... year’s most outstanding franchise, walking away with the coveted David Wright Award of ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
(Date:2/5/2016)... ... , ... Colorize is a web theme package created exclusively for ... Colorize's dynamic moving camera. Colorize is perfect for personal and web related videos and ... 1 to 5 focus points per scene, stage floor scene presets that are great ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Feb. 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... has entered into a settlement agreement with the ... resolving the SEC,s investigation into possible violations of ... terms of the settlement agreement, SciClone has agreed ... disgorgement, pre-judgment interest and a penalty.  This payment ...
(Date:2/4/2016)... -- Frontier Pharma: Chronic Obstructive Pulmonary Disease (COPD) ... Chronic Obstructive Pulmonary Disease (COPD) is a ... airways and lungs. Persistent breathing difficulties and repeated ... of the leading causes of morbidity and the ... is linked to cumulative exposure to risk factors, ...
(Date:2/4/2016)... ALBANY, N.Y. , Feb. 4, 2016  AMRI (NASDAQ: ... Vice President of Pfizer Inc. and President of Pfizer Global ... effective as of February 4, 2016. In addition, the Company ... member of the audit committee since 2010, has retired from ... time and attention to his other business ventures.  ...
Breaking Medicine Technology: